Scientists at the Biodesign Institute at Arizona State University have received a 2-year, $5.3 million grant from the Defense Advanced Research Projects Agency (DARPA) to protect warfighters in the event of exposure to infectious diseases during deployment.
Dr. Stephen Albert Johnston and his... Read More
While attention in the Gulf has mostly focused on oil, the explosion and spill also released tremendous amounts of natural gas. David Valentine, a microbial geochemistry professor at UC Santa Barbara, and his research team, have been studying the behavior and distribution of these natural gases,... Read More
Rocco Mancinelli, an astrobiologist from the Bay Area Environmental Research Institute, discusses how research has taken the first step to understanding how organisms survive and evolve outside of planet earth. Read More
DOE JGI's Igor Grigoriev and University of Utrecht's Han Wosten discuss the split-gill mushroom, a wood-degrading fungus whose genome was published online July 11, 2010 in Nature Biotechnology.
MicrobeWorld Video and This Week in Virology team up to bring you a tour of the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA. In this episode the host of TWiV, Vincent Racaniello, speaks with exhibitors and visitors, including Professors Read More
Within a year, the debate over whether a mouse virus causes chronic fatigue syndrome is likely to be settled, a prominent researcher told MedPage Today in an exclusive InFocus video interview here at the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Two teams have now clai... Read More
Live press conference from ICAAC in Boston featuring:
* Mark Krockenberger, University of Syndey, New South Wales, Australia
* Daniel Frank, University of Colorado, Boulder, CO, United States
* Paul Johnson, Austin Health, Melbourne, Australia
As technology continues to move forward, fast DNA-based tests can offer diagnosis in hours compared to the days it can take for a bacterial culture to grow, often with the same level of certainty. Still, cultures remain the definitive gold-standard for confirming diagnosis. Have we finally rea... Read More
Methicillin-resistant Staphylococcus aureus (MRSA) was discovered in 1960. Over the following 40 years, MRSA was a problem confined largely to the health-care setting. In the late 1990s, the first United States reports of community-associated MRSA (CA-MRSA) infections appeared. At present, sever... Read More
Statins are well-known as a class of drugs that are used to help lower cholesterol but recent evidence suggests they might be good for more than your heart. They may play a role in preventing and treating certain bacterial infections including pneumonia and sepsis. Presenters at ICAAC discuss ... Read More
Members of the ICAAC Program Committee give an overview of the ICAAC meeting and discuss sessions of particular interest. Lunch will follow.
* M. Lindsay Grayson, Austin Hospital/Austin Health, Melbourne, Australia
* Craig Rubens, Children’s Hospital & Regional Medical Center, Seatt... Read More
Participants in this session at ICAAC discuss the latest issues appearing on the horizon for infectious disease researchers including the changing epidemiology of drug resistance in Salmonella and the possibility that chronic fatigue syndrome could be associated with a retroviral infection.
... Read More
Mom's advice about cleaning your hands may finally be starting to get through. In the August 2010 observational study sponsored by the American Society for Microbiology and the American Cleaning Institute® (formerly The Soap and Detergent Association), 85% of adults washed their hands in public ... Read More
New Dehli metallo-beta-lactamase-1 (NDM-1) is an enzyme that makes bacteria resistant to a broad range of beta-lactam antibiotics. These include the antibiotics of the carbapenem family, which are a mainstay for the treatment of antibiotic-resistant bacterial infections. According the the Unite... Read More
Antibiotic resistance has become an increasing cause for concern around the globe, but it poses a unique set of problems for infections in children. Researchers present the latest information on antibiotic-resistant infections of concern to pediatricians including methicillin-resistant Staphylo... Read More
As larger pharmaceutical companies have reduced focus on discovery and early development of antibacterials, smaller biotech companies have taken on a larger role in these earliest stages of antibacterial development, later licensing or selling the compound to the pharmaceutical company to com... Read More
The Krazy Kuzins are back at it with a quick video about the importance of washing your hands and staying healthy! Check it out! Read More
It,s being called a superbug, a virus that is resistant to drugs, and is being transmitted through patients who've visited India for medical treatment. Britain has already advised its citizens against travelling to India for medical treatment. Aafreen Alam reports. Read More
Scientists at the Welsh School of Pharmacy say the first human clinical trials on a new drug to treat infections caused by the Hepatitis C virus have been successful.
Researchers say the new medication could now become an approved treatment.
300,000 people suffer from Hepatitis C in the UK... Read More
Dr. Nina Salama, microbiologist at Fred Hutchinson Cancer Research Center and Affiliate Associate Professor of Microbiology at the University of Washington discusses Helicobacter pylori, a bacterira that lives in the human stomach and causes chronic disease (peptic ulcer and gastric cancer).
... Read More